This conference will bring together stakeholders from across the healthcare ecosystem, including researchers, policymakers, HTA bodies, payers, clinicians, industry, and patient representatives.

Centered on health economics and outcomes research (HEOR), the conference will spotlight how rigorous evidence and transparent methods can inform real-world decisions on value assessment, pricing and reimbursement, real-world evidence, innovative payment models, and patient-centered outcomes.

MULTIPULM partner PharmEcons will attend to contribute insights from its work on the project’s sustainability and upscaling activities.

Within MULTIPULM, PharmEcons focuses on the economic evaluation of the medical and digital technologies being tested, and is currently conducting a systematic literature review on the economic burden of COPD and asthma in Serbia, Türkiye, and Brazil.

Stay tuned as we share highlights and key takeaways from Vienna following the event.